{"id":8784,"date":"2024-12-25T07:38:34","date_gmt":"2024-12-25T05:38:34","guid":{"rendered":"https:\/\/medilab.km.ua\/?p=8784"},"modified":"2026-04-20T18:54:44","modified_gmt":"2026-04-20T15:54:44","slug":"what-oncomarkers-are-needed-to-know-for-health-control","status":"publish","type":"post","link":"https:\/\/medilab.km.ua\/en\/what-oncomarkers-are-needed-to-know-for-health-control\/","title":{"rendered":"Tumor marker levels: what you need to know to monitor your health"},"content":{"rendered":"

When we talk about oncology, most of us imagine complex diagnostics, long-term treatment, and unpredictable consequences. But modern medicine has tools that allow us to \u00absee\u00bb potential danger even before symptoms appear. One of them is analysis for tumor markers<\/strong>. This study does not give a direct answer "is there cancer or not", but it may to warn in time<\/strong> about the risks, suggest the direction of examination and become a reference point in postoperative monitoring.<\/p>\n

People are often scared by the term "tumor marker", not understanding that there can be many reasons for these indicators to increase. That is why it is important to understand: what the level of tumor markers means, when it is worth taking the analysis and how to correctly interpret the results.<\/p>\n

What are tumor markers?<\/strong><\/h3>\n

Tumor markers<\/a> \u2014 these are specific substances (mainly proteins or enzymes) that are formed in the body under conditions active growth of tumor cells<\/strong> or under the influence of the tumor on the surrounding tissues<\/strong>. They may be present in blood, urine, cerebrospinal fluid, or other biological media.<\/p>\n

Tumor markers are not a universal "cancer test," but their levels can indicate:, in which direction to look<\/strong>, if suspicious symptoms appear or there is a hereditary predisposition.<\/p>\n

How do tumor marker levels change?<\/strong><\/h3>\n

Tumor marker levels can:<\/p>\n

    \n
  • \n

    to be elevated even in a healthy person<\/strong> (e.g. during infection or chronic inflammation)<\/p>\n<\/li>\n

  • \n

    remain within normal limits<\/strong> in the presence of oncology in the early stages<\/p>\n<\/li>\n

  • \n

    to change under the influence physical activity, stress, diet, medication<\/strong><\/p>\n<\/li>\n

  • \n

    give physiological fluctuations<\/strong>, for example, in women at different phases of the menstrual cycle<\/p>\n<\/li>\n<\/ul>\n

    That's why one result is not a reason to panic<\/strong>, but what is important is the dynamics: how the marker level changes over time.<\/p>\n

    The most common tumor markers<\/strong><\/h3>\n
    \n\n\n\n\n\n\n\n\n\n\n\n
    Tumor marker name<\/th>\nPossible associated diseases<\/th>\nComment<\/th>\n<\/tr>\n<\/thead>\n
    CEA<\/strong><\/a><\/td>\nCancer of the intestine, stomach, lungs<\/td>\nMay be elevated in smokers and with cirrhosis<\/td>\n<\/tr>\n
    PSA<\/strong><\/td>\nProstate cancer<\/td>\nImportant in men 45+; sensitive marker<\/td>\n<\/tr>\n
    CA 125<\/strong><\/td>\nOvarian cancer<\/td>\nMay increase during menstruation and endometriosis<\/td>\n<\/tr>\n
    CA 19-9<\/strong><\/td>\nPancreatic cancer<\/td>\nSometimes increases with pancreatitis or jaundice<\/td>\n<\/tr>\n
    HE4<\/strong><\/a><\/td>\nEpithelial ovarian cancer<\/td>\nOften used with CA 125 to increase accuracy<\/td>\n<\/tr>\n
    AFP<\/strong><\/td>\nLiver cancer, testicular cancer<\/td>\nAlso increases in chronic hepatitis<\/td>\n<\/tr>\n
    SCC<\/strong><\/td>\nSquamous cell carcinomas<\/td>\nNeck, cervix, head, lungs<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

    \"Table<\/h3>\n

    In which cases is the study recommended?<\/strong><\/h3>\n
      \n
    • \n

      If available complaints that cause oncological alertness<\/strong> (weight loss, bleeding, persistent pain)<\/p>\n<\/li>\n

    • \n

      After completion of treatment cancer<\/strong> \u2014 for relapse monitoring<\/strong><\/p>\n<\/li>\n

    • \n

      If there were cases in the family hereditary cancer<\/strong><\/p>\n<\/li>\n

    • \n

      For control the effectiveness of chemotherapy or radiation therapy<\/strong><\/p>\n<\/li>\n

    • \n

      During a preventive examination (especially after 40\u201345 years of age)<\/p>\n<\/li>\n<\/ul>\n

      In some cases, tumor markers are part of comprehensive screening<\/strong>, but only on the recommendation of a doctor.<\/p>\n

      What does leveling up mean?<\/strong><\/h3>\n

      Elevated tumor marker \u2260 cancer. Here are examples of reasons that can affect the result:<\/p>\n

        \n
      • \n

        acute or chronic inflammation<\/p>\n<\/li>\n

      • \n

        benign tumors<\/p>\n<\/li>\n

      • \n

        complicated diseases of the liver, kidneys, stomach<\/p>\n<\/li>\n

      • \n

        pregnancy (e.g., AFP in women in the second trimester)<\/p>\n<\/li>\n

      • \n

        postoperative period<\/p>\n<\/li>\n

      • \n

        violation of the rules for preparing for analysis<\/p>\n<\/li>\n<\/ul>\n

        Simultaneously, a sharp increase in the indicator or a steady upward trend<\/strong> may be a signal for ultrasound, MRI, CT scan, or biopsy.<\/p>\n

        How to prepare for the analysis<\/strong><\/h3>\n
          \n
        • \n

          analysis is performed with venous blood<\/strong>, mostly in the morning on an empty stomach<\/strong><\/p>\n<\/li>\n

        • \n

          24 hours before blood collection do not drink alcohol, fatty foods, coffee<\/strong><\/p>\n<\/li>\n

        • \n

          avoid physical exertion, stress<\/p>\n<\/li>\n

        • \n

          women are recommended to take CA 125 and HE4 on day 5\u20137 of the cycle<\/strong><\/p>\n<\/li>\n

        • \n

          do not take medications that affect the liver, kidneys or hormonal levels without consulting a doctor<\/p>\n<\/li>\n<\/ul>\n

          What to do with the results<\/strong><\/h3>\n
            \n
          • \n

            consult a doctor who interprets the analysis in the context of the overall condition<\/strong><\/p>\n<\/li>\n

          • \n

            if necessary, undergo additional instrumental examinations<\/p>\n<\/li>\n

          • \n

            not to try decipher the result yourself<\/strong>, especially without knowledge of the clinical picture<\/p>\n<\/li>\n

          • \n

            if the marker level is normal, don't forget about preventive examinations every year<\/strong><\/p>\n<\/li>\n

          • \n

            if an increase is detected, remain calm and act according to the algorithm recommended by a specialist<\/p>\n<\/li>\n<\/ul>\n

            Advantages and limitations<\/strong><\/h3>\n

            Advantages:<\/strong><\/p>\n

              \n
            • \n

              possibility detect recurrence at an early stage<\/strong><\/p>\n<\/li>\n

            • \n

              monitoring the effectiveness of treatment<\/p>\n<\/li>\n

            • \n

              assessment tool individual risks<\/strong><\/p>\n<\/li>\n

            • \n

              affordable and non-invasive method<\/strong><\/p>\n<\/li>\n<\/ul>\n

              Limitation:<\/strong><\/p>\n

                \n
              • \n

                no 100% specificity or sensitivity<\/strong><\/p>\n<\/li>\n

              • \n

                requires combination with other diagnostic methods<\/p>\n<\/li>\n

              • \n

                possible false positive or negative results<\/strong><\/p>\n<\/li>\n

              • \n

                not every type of tumor produces tumor markers<\/p>\n<\/li>\n<\/ul>\n

                Cancer marker testing is not a panacea, but a powerful medical diagnostic tool that, in combination with other methods, helps maintain health and detect a problem before it becomes a threat. This is a chance to gain an advantage in the fight for your life - thanks to an early signal from within.<\/p>","protected":false},"excerpt":{"rendered":"

                When we talk about oncology, most of us imagine complex diagnostics, long-term treatment, and unpredictable consequences. But modern medicine has<\/p>","protected":false},"author":627,"featured_media":8785,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8784","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/8784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/users\/627"}],"replies":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/comments?post=8784"}],"version-history":[{"count":0,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/8784\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media\/8785"}],"wp:attachment":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media?parent=8784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/categories?post=8784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/tags?post=8784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}